marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Vertex Pharmaceuticals Incorporated Financial Statements 2011-2024 | VRTX
Annual Financial Statements Vertex Pharmaceuticals Incorporated
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
110 B | 76.1 B | 56.6 B | 61.4 B | 59.1 B | 47.6 B | 41.4 B | 20.6 B | 21.9 B | 25.9 B | 18.5 B | 9.46 B | 7.12 B |
Shares |
258 M | 256 M | 258 M | 260 M | 257 M | 254 M | 249 M | 245 M | 241 M | 235 M | 225 M | 212 M | 205 M |
Historical Prices |
426 | 297 | 220 | 236 | 219 | 166 | 150 | 73.7 | 126 | 119 | 74.3 | 41.9 | 33.2 |
Net Income |
3.62 B | 3.32 B | 2.34 B | 2.71 B | 1.18 B | 2.1 B | 263 M | -112 M | -556 M | -739 M | -445 M | -107 M | 29.6 M |
Revenue |
9.87 B | 8.93 B | 7.57 B | 6.21 B | 4.16 B | 3.05 B | 2.49 B | 1.7 B | 1.03 B | 580 M | 1.21 B | 1.53 B | 1.41 B |
Cost of Revenue |
1.26 B | 1.08 B | 904 M | 736 M | 548 M | 410 M | 275 M | 210 M | - | - | - | - | - |
Gross Profit |
- | - | - | - | 3.62 B | 2.64 B | 2.21 B | 1.49 B | 908 M | 519 M | 1.08 B | 1.25 B | 1.33 B |
Operating Income |
3.83 B | 4.31 B | 2.78 B | 2.86 B | 1.2 B | 635 M | 123 M | 9.94 M | -467 M | -692 M | -610 M | 46.7 M | 114 M |
Interest Expense |
-22.8 M | -165 M | 4.9 M | 297 M | 58.5 M | 72.5 M | 69.3 M | 4.13 M | -6.72 M | 30.4 M | 6.89 M | 16.7 M | 38.5 M |
EBITDA |
4.01 B | 4.46 B | 2.91 B | 2.97 B | 1.31 B | 736 M | 454 M | 72.6 M | -402 M | -578 M | -151 M | 42.4 M | 257 M |
Operating Expenses |
- | - | - | - | 2.41 B | 1.97 B | 1.82 B | 1.48 B | 1.37 B | 1.16 B | 1.28 B | 1.24 B | 1.11 B |
General and Administrative Expenses |
1.14 B | 945 M | 840 M | 770 M | 658 M | 558 M | 496 M | 433 M | 377 M | 305 M | 362 M | 437 M | 401 M |
All numbers in USD currency
Quarterly Income Statement Vertex Pharmaceuticals Incorporated
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
258 M | 258 M | 258 M | 258 M | 258 M | 258 M | 257 M | 257 M | 256 M | 256 M | 255 M | 254 M | 258 M | 259 M | 259 M | 260 M | 260 M | 260 M | 260 M | 258 M | 257 M | 256 M | 256 M | 255 M | 255 M | 254 M | 253 M | 252 M | 250 M | 248 M | 246 M | 245 M | 245 M | 244 M | 244 M | 243 M | 242 M | 241 M | 239 M | 238 M | 236 M | 234 M | 233 M | 231 M | 231 M | 222 M | 215 M | 215 M | 214 M | 211 M | 208 M | 207 M | 206 M | 204 M | 202 M |
Net Income |
1.05 B | -3.59 B | 1.1 B | - | 1.04 B | 916 M | 700 M | - | 930 M | 810 M | 762 M | - | 852 M | 66.9 M | 653 M | 604 M | 667 M | 837 M | 603 M | 583 M | 57.5 M | 267 M | 269 M | 1.55 B | 129 M | 207 M | 210 M | 101 M | -103 M | 18 M | 248 M | 32.9 M | -38.8 M | -64.5 M | -41.6 M | -73.7 M | -95.1 M | -189 M | -199 M | -177 M | -170 M | -159 M | -232 M | 44.3 M | -124 M | -57.2 M | -308 M | -76.1 M | -57.5 M | -64.9 M | 91.6 M | 159 M | 221 M | -174 M | -176 M |
Revenue |
2.77 B | 2.65 B | 2.69 B | - | 2.48 B | 2.49 B | 2.37 B | - | 2.33 B | 2.2 B | 2.1 B | - | 1.98 B | 1.79 B | 1.72 B | 1.63 B | 1.54 B | 1.52 B | 1.52 B | 1.41 B | 950 M | 941 M | 858 M | 870 M | 785 M | 752 M | 641 M | 652 M | 578 M | 544 M | 715 M | 459 M | 414 M | 432 M | 398 M | 418 M | 310 M | 166 M | 139 M | 145 M | 179 M | 138 M | 118 M | 351 M | 222 M | 311 M | 328 M | 334 M | 336 M | 418 M | 439 M | 563 M | 659 M | 114 M | 73.7 M |
Cost of Revenue |
393 M | 372 M | 343 M | - | 319 M | 309 M | 267 M | - | 289 M | 262 M | 246 M | - | 236 M | 228 M | 192 M | 203 M | 186 M | 185 M | 162 M | 185 M | 132 M | 136 M | 95.1 M | 122 M | 111 M | 104 M | 71.6 M | 84.1 M | 72.9 M | 71.2 M | 47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
1.12 B | -3.51 B | 1.14 B | - | 1.04 B | 1.03 B | 779 M | - | 1.13 B | 1.11 B | 1.04 B | - | 1.05 B | -38 M | 888 M | 746 M | 672 M | 718 M | 720 M | 551 M | 99.3 M | 270 M | 277 M | 128 M | 206 M | 173 M | 129 M | 126 M | -326 M | 52.7 M | 271 M | 39.6 M | -18.7 M | 3.35 M | -14.3 M | -53.7 M | -70 M | -171 M | -172 M | -154 M | -142 M | -181 M | -216 M | -10.3 M | -124 M | -47 M | -429 M | -77.5 M | -1.07 M | -10.8 M | 91.6 M | 224 M | 216 M | -166 M | -160 M |
Interest Expense |
-16.9 M | -23.1 M | -31.2 M | - | -15.9 M | 1.6 M | 1.3 M | - | 17.2 M | -78.1 M | -72.8 M | - | 42.4 M | 8.05 M | -52.7 M | 16.3 M | 13.9 M | 13.9 M | 14.1 M | 14.2 M | 14.5 M | 14.8 M | 14.9 M | 18.7 M | 18.7 M | 18.2 M | 16.9 M | -748 K | -77.6 M | -2.54 M | -544 K | 1.1 M | -167 K | -1.22 M | 4.41 M | -1.69 M | -1.33 M | 1.41 M | -5.11 M | -3.79 M | -3.99 M | 37.7 M | 451 K | 3.34 M | 4.76 M | -34 K | -1.18 M | 33 K | -13 K | -179 K | -150 K | 12.4 M | 7.06 M | 6.96 M | 12 M |
EBITDA |
- | - | 1.19 B | - | - | - | 818 M | - | 1.24 B | 1.11 B | 1.08 B | - | 1.15 B | -38 M | 917 M | 746 M | 752 M | 772 M | 747 M | 551 M | 180 M | 325 M | 304 M | 128 M | 259 M | 207 M | 145 M | 126 M | -281 M | 82.4 M | 286 M | 39.6 M | 27.2 M | 34.7 M | 2.08 M | -53.7 M | -23.4 M | -141 M | -156 M | -154 M | -95.3 M | -151 M | -200 M | -10.3 M | -92.8 M | -25.8 M | -418 M | -77.5 M | 24.7 M | 6.46 M | 100 M | 224 M | 241 M | -148 M | -151 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
372 M | 372 M | 343 M | - | 264 M | 263 M | 241 M | - | 247 M | 215 M | 215 M | - | 198 M | 195 M | 192 M | 212 M | 185 M | 192 M | 182 M | 195 M | 160 M | 157 M | 147 M | 153 M | 137 M | 137 M | 130 M | 135 M | 121 M | 127 M | 113 M | 110 M | 106 M | 112 M | 105 M | 96.5 M | 99.8 M | 94.4 M | 85.9 M | 78.5 M | 75.2 M | 77.4 M | 74.2 M | 73.1 M | 86.4 M | 105 M | 91.6 M | 110 M | 97.7 M | 118 M | 111 M | 122 M | 111 M | 96.7 M | 71.5 M |
All numbers in USD currency